What is Giving Compass?
We connect donors to learning resources and ways to support community-led solutions. Learn more about us.
Giving Compass' Take:
• Global Health NOW highlights a recent global report showing a rise in research funding for neglected diseases, however there could be a debate over it's validity.
• How can disease funders examine their own data and evaluate their contributions? What specific areas or diseases are lacking the most funding?
Funding for neglected diseases that afflict some 1 billion people reached a record high in 2017, commanding $3.6 billion. That’s a 7% jump from 2017 and the most since 2007, according to a new report from Sydney-based think tank Policy Cures Research.
More funding for drugs tackling multiple diseases at once and promising developments for Ebola drugs fueled much of the 2017 surge, Nature reported. A handful of top public sector funders dominated the shift, including the US and India. UK funding rose 89%.
But there were data gaps: The researchers noted that they didn’t have numbers on contributions from Russia and China, BBC reported.
Read the full article about funding research for neglected diseases at Global Health NOW